DeviceDiagnosticPartnershipTherapeutic Imperial Confidence in Concept Scheme Awards 2016
The BRC has directly co-funded 4 projects through the most recent round of the Imperial Confidence-in-Concept funding scheme. These projects are;
G Mylonas, In vivo validation of an inflatable robot for endoscopic tumour dissection (£73,641)
V Terzidou, Circulating miRNAs for the prediction of women at risk of preterm delivery (£79,925)
A Porter, Targeted zinc oxide nanowires as theranostics for triple negative breast cancer (£74,441)
M Levin, Development and validation of a 2 gene RNA test to detect bacterial infection (£80,262)
Based on an £800,000 MRC ‘Confidence in Concept’ award to the College to ‘pump–prime’ the translation of novel therapeutics, devices and diagnostics, and together with support from the BRC, the À¶Ý®ÊÓƵ BRC at the Royal Marsden and Institute of Cancer Research, Chelsea & Westminster Hospital NHS Foundation Trust and the Imperial College Wellcome Trust Institutional Strategic Support Fund (ISSF), these schemes have created a project-managed fund in excess of £1.3M to identify early targets and technologies, not currently being developed, within the Faculties of Medicine, Natural Sciences and Engineering, to enter into the drug, devices and diagnostics development pathway.
